Metabolism of roquinimex in mouse and rat: an in vitro/in vivo comparison

References

• BOCK, K. W., Lipp, H-P. and BOCK-HENNIG, B. S., 1990, Review: Induction of drug-metabolising enzymes by xenobiotics. Xenobiotica, 20, 1101–1111.
   Google Scholar
• BOOBIS, A. R., SESARDIC, D., MURRAY, B. P., EDWARDS, R. J., SINGELTON, A. M., RICH, K. J., MURRAY, S., DE LA TORRE, R., SEGURA, J., PELKONEN, O., PASANEN M., KOBAYASHI, S., ZHI -GUANG, T. and DAVIES, D. S., 1990, Species variation in the response of the cytochrome P-450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica, 20, 1139–1161.
   Google Scholar
• ERNSTER, L., SIEKEVITZ, P. and PALADE G. E., 1962, Enzyme—structure relationships in the endoplasmic reticulum of rat liver. Journal of Cell Biology, 15, 541–562.
   Google Scholar
• GIBALDI, M. and PERRIER, D., 1982, Pharmacokinetics, 2nd edn (New York. Marcel Dekker).
   Google Scholar
• GONZALEZ, F. J., 1989, The molecular biology of cytochrome P450s. Pharmacology Reviews, 41, 91–92.
   Google Scholar
• GONZALEZ, F. J., SONG, B. -J. and HARDWICK, J. P., 1986, Pregnenolone 16 a-carbonitrile -inducible P450 gene family: gene conversion and differential regulation. Molecular Cell Biology, 6, 2969–2976.
   Google Scholar
• KARUSSIS, D. M., LEHMANN, D., SLAVIN, S., KALLAND, T., VOURKA-KARUSSIS, U., MIZRACHI -KOLL, OVADIA, H. and ABRAMSKY, O., 1995, Immunomodulation of autoirnmunity by Linomide. Israel Journal of Medical Science, 31, 38–41.
   Google Scholar
• KARUSSIS, D. M., LEHMANN, D., SIAVIN, S., VOURKA-KARUSSIS, U., MIZRACHE -KOLL, R., OVADIA, H., KALLAND, T. and ABRAMSKY, O., 1993, Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator Linomide (quinoline-3-carboxamide). Proceedings of the National Academy of Sciences, USA, 90, 6400–6404.
   Google Scholar
• LARREY, D., TINEL, M. and PESSAYRE, D., 1983, Formation of inactive cytochrome P450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. Biochemical Pharmacology, 32, 1487–1492.
   PubMed Web of Science ®Google Scholar
• LINEWEAVER, H. and BURKE, D., 1934, The determination of enzyme dissociation constants. journal of the American Chemical Society, 56, 658–666.
   Web of Science ®Google Scholar
• Lu, A. H. and LEWIN, W., 1972, Partial purification of cytochromes P450 and P448 from rat liver micro somes. Biochemical and Biophysical Research Communications, 46, 1334–1339.
   PubMed Web of Science ®Google Scholar
• MANNERING, G. J., SHOEMAN, J. A. and DELOIUA, L. B., 1992, Identification of the antibiotic hops component, colupulone as an inducer of hepatic cytochrome P4503A in the mouse. Drug Metabolism and Disposition, 20, 142–147.
   PubMed Web of Science ®Google Scholar
• MASAKI, R., MATSUURA, S. and TASHIRO, Y., 1984, A biochemical and electron microscopic study of changes in the content of cytochrome P450 in rat livers after cessations of treatment with phenobarbital, /3-naphtofiavone or 3-methylcholantrene. Cell Structure and Functions, 9, 53–66.
   PubMed Web of Science ®Google Scholar
• NEBERT, D. W. and GONZALEZ, F. J., 1987, P450 genes: structure, evolution and regulation. Annual Reviews in Biology, 56, 945–993.
   Google Scholar
• NEBERT, D. W., NELSON, D. R. and FEYEREISEN, R., 1989, Evolution of the cytochrome P450 genes. Xenobiotica, 19, 1149–1160.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN, J. J., FEYEREISEN, R., WAKVIAN, D. J., WATERMAN, M. R., GOTOH O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• SAS/STAT, 1989, User's Guide, Version 6, 4th edn, vol. 1 (Cary: SAS Institute).
   Google Scholar
• SIMMONS, D. L., LALLEY, P. A. and KASPER, C. B., 1985, Chromosomal assignment of genes coding for component of the mixed-function oxidase system in mouse. Journal of Biological Chemistry, 260, 515–521.
   PubMed Web of Science ®Google Scholar
• SLAVIN, S., Sror, H., WEISS, L., ROSENMAN, E., KALLAND, T. and GROSS, D., 1993, Linomide, a new treatment for autoimmune diseases: The potential in type I diabetes. Diabetes Metabolism Reviews, 9, 311–315.
   PubMedGoogle Scholar
• SOUCEK, P. and GUT, I., 1992, Review. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica, 22, 83–103.
   PubMed Web of Science ®Google Scholar
• TARKOWSKI, A., GUNNARSSON, K. and STALHANSKE, T., 1986a, Effects of LS 2616 administration upon the autoimmune disease of (NZB X NZW) Flo hybrid mice. Immunology, 59, 589–594.
   PubMed Web of Science ®Google Scholar
• TARKOWSKI, A., GUNNARSSON, K., NILSSON, L. A., LINDHOLM, L. and STALHANSKE, T., 1986b, Successful treatment of autoimmunity in MRL/1 mice with LS 2616, a new immunomodulator. Arthritis and Rheumatism, 29, 1405–1409.
   PubMed Web of Science ®Google Scholar
• TIVERON C., HARTLEY -ASP, B., JOHANSSON, C. J. and PACCHIEROTTI, F., 1993, Noscapine does not show aneugenic activity in mouse oocytes. Mutagenesis, 8, 311–315.
   Google Scholar
• WIN NONLIN, 1997, Professional User's Guide, vers 1.5 (Lexington: Scientific Consulting, Inc.).
   Google Scholar
• XuE-JUN, Z. and TAKASH I., 1997, The in vitro hepatic metabolism of quinine in mice, rats and dogs:comparison with human liver microsomes. Journal of Pharmacology and Experimental Thera-peutics, 283, 1168–1176.
   PubMedGoogle Scholar